Robert F. Johnston is the Founder and President of Johnston Associates. See sector focus and contact routes.
Robert F. Johnston is the Founder and President of Johnston Associates, a venture capital firm he established in 1968 to provide seed capital for biotechnology and healthcare startups. His investment thesis focuses exclusively on early-stage healthcare companies, with a specific emphasis on the pharmaceutical and biotechnology sectors within the United States. The firm typically invests check sizes around the seed level, with Johnston Associates managing approximately $40 million in capital as of recent firm profiles. Johnston frequently leads investments and has founded or helped form numerous notable public companies, including Sepracor, Cytogen, I-STAT, Genex, and Envirogen. He also played instrumental early roles in private companies such as Immunicon, Praelux, and Targent, many of which were later sold to major pharmaceutical or industrial firms. Johnston’s distinctive point of view centers on recognizing the industrial implications of life sciences advances during the 1970s, which guided his founding of recombinant DNA and monoclonal antibody companies. He serves on the Advisory Council of Princeton University’s molecular biology department and has no
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Princeton.
Investors like Robert F. Johnston · Full investor directory · Investor access · Company funding database